News

Deal Announcements

MacuLogix Raises $5 Million Venture Capital Equity

Tuesday, August 4, 2015 5:44:00 AM PDT | VentureDeal
   Hummelstown, Pennsylvania  --  Medical diagnostic device maker MacuLogix has received $5 million in new venture capital equity financing, according to an SEC regulatory filing.

MacuLogix has developed a diagnostic system to detect age-related macular degeneration symptoms.

Investors in the financing were not disclosed, nor was how the company intends to use the funding proceeds.

Company CEO John Edwards has been with the firm since 2008.

MacuLogix is backed by a syndicate of strategic and private equity firms.

Email Page  Email Page | Print Page Print Page

Free Trial

Want unlimited access to the complete database with thousands of technology companies, VCs and transactions for only $25 per month?

Start your Free 14 Day Trial now – no obligation or credit card required.

Free 14 day trial. No Obligation. Click to Register.
Venturedeal Twitter Venturedeal Facebook Venturedeal Linkedin


PCI - Level1